Concepedia

Lei Jiang

LJ

Statistics

Publications

2

Citations

119

H-Index

2

Active since

2023

Affiliations

Hubei University(Current)

Lei Jiang is an author at Hubei University specializing in antiviral drug design, sars-cov-2 antiviral therapy, and treatment of coronavirus infections.

ORCID

Publications per year

2023–2024

2

Publications

2

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir

Xiangrui Jiang, Haixia Su, Weijuan Shang et al. · Nature Communications · 2023 · 107 citations · Full text

, , +12

Inhibition of colorectal cancer in Alzheimer’s disease is mediated by gut microbiota via induction of inflammatory tolerance

Nan Zhang, Rui Zhang, Lei Jiang et al. · Proceedings of the National Academy of Sciences · 2024 · 12 citations · Full text

, , +16

1–2 of 2